Functional insufficiency of the pancreas and the metabolic activity of the microbiota in cystic fibrosis adults patients


Cite item

Full Text

Abstract

In order to optimize the therapy, the functional state of the pancreas (P) and the peculiarities of metabolic activity of intestinal microbiota in adults with cystic fibrosis (CF) were assessed. Materials and methods. 14 CF patients (20-34 years, 7 men, 7 women) were enrolled. In 8 patients, the diagnosis was confirmed in the first year of life on the basis of clinical data, positive sweat test, 5 had genetic confirmation. In 4 patients, the diagnosis was confirmed at the age of 8-13 years and 2 patients aged 18, 27 years. In this group, genetic confirmation was in 4 subjects. In addition to general clinical studies, the level of C-peptide in blood, elastase and the concentration of short chain fatty acids in feces was determined. Results and discussion. Of elastase feces in 9 patients was 5.5±4.7 icg/g, that is revealed severe exocrine insufficiency of the pancreas and in 5 patients the elastase level was normal and amounted to 402±124 icg/g. Deployed the clinical picture of diabetes mellitus was observed in 3 patients. Metabolic activity of the colon microflora as a whole was reduced, the sum of the concentration of short-chain fatty acids (ΣCn) was 6.03±4.11 mg/g at a rate of 10.61±5.11 (p<0.05). At the same time, in some patients (group 1, n=9), who were at the time of the study on antibiotic therapy, the value of ΣCn was 3.32±0.33 mg/g, and in patients receiving probiotic drugs (group 2, n=5), the activity of microflora did not differ from the norm ((ΣCn=11.03±2.01 mg/g). The correlation dependence of the ratio of the total iso-acids fraction in patients with MV to the normal values and the level of fecal elastase (r= -0.46, p=0.049) was revealed. Conclusion. Most patients with CF (64%) diagnosed with exocrine pancreatic insufficiency severe according elastase stool. The activity of faecal elastase correlated with parameters of microbiocenosis, which indicates the necessity of correction is not only functional insufficiency of the pancreas, but also the state of the microbiota.

About the authors

L V Vinokurova

A.S.Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department

Email: vinokurova52@mail.ru
д.м.н., в.н.с. отд-ния патологии поджелудочной железы и желчных путей МКНЦ им. А.С. Логинова

G E Baimakanova

A.S.Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department

д.м.н., зав. отд. пульмонологии МКНЦ им. А.С. Логинова ДЗМ

S A Krasovsky

Research Institute of Pulmonology

к.м.н., с.н.с. лаб. муковисцидоза НИИ пульмонологии

S Yu Silvestrova

A.S.Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department

к.б.н., с.н.с. лаб. лекарственного метаболизма МКНЦ им. А.С. Логинова ДЗМ

E A Dubtsova

A.S.Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department

д.м.н., зав. отд-нием патологии поджелудочной железы и желчных путей МКНЦ им. А.С. Логинова ДЗМ

G G Varvanina

A.S.Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department

д.м.н., с.н.с. лаб. научно-диагностических исследований МКНЦ им. А.С. Логинова ДЗМ

D S Bordin

A.S.Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department

д.м.н., зав. отд. патологии поджелудочной железы, желчных путей и верхних отделов пищеварительного тракта МКНЦ им. А.С. Логинова ДЗМ, проф. каф. общей врачебной практики (семейной медицины) ФДПО, интернатуры и ординатуры Тверского ГМУ, ученый секретарь «Панкреатологического клуба»

References

  1. Robertson M.B, Choe K.A, Joseph P.M. Review of the Abdominal Manifestations of Cystic Fibrosis in the Adult Patient. RadioGraphics. 2006;26:679-690. doi: 10.1148/rg.263055101
  2. World Health Organization (WHO). The molecular genetic epidemiology of cystic fibrosis. Report of a Joint Meeting of WHO. Genoa, Italy, 19 June 2002. Human genetics programme. 2004; 24 p. http://www.who.int/iris/handle/10665/68702
  3. Капранов Н.И., Каширская Н.Ю. Муковисцидоз. Москва: Медпрактика-М; 2014. 671 с.
  4. Coffey M.J, Ooi Ch.Y. Pancreatitis in Cystic Fibrosis and CFTR-Related Disorder. Available at: www.intechopen.com. doi: 10.5772/27861
  5. Koch C, Cuppens H, Rainisio M, et al. Investigators of the ERCF European Register of Cystic Fibrosis (ERCF): comparison of major disease mainfestations between patients with different classes of mutations. Pediatr Pulmonol. 2001;31(1):1-12. doi: 10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T
  6. Boat T.F. Cystic fibrosis. In: Behrman R.E, Kliegman R.M, Jenson H.B, eds. Nelson textbook of pediatrics. 17th ed. Philadelphia, Pa: Saunders; 2004. P. 1437-1450. NLM ID:101555489 [Book].
  7. Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis D.E. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest. 2004;126:1215-1224. doi: 10.1378/chest.126.4.1215
  8. Lugo-Olivieri C.H, Soyer P.A, Fishman E.K. Cystic fibrosis: spectrum of thoracic and abdominal CT findings in the adult patient. Clin Imaging. 1998;22:346-354. PMID: 9755398.
  9. Agrons G.A, Corse W.R, Markowitz R.I, Suarez E.S, Perry D.R. Gastrointestinal manifestations of cystic fibrosis: radiologic - pathologic correlation. RadioGraphics. 1996;16:871-893. doi: 10.1148/radiographics.16.4.8835977
  10. Gibson-Corley K.N, Meyerholz1 D.K, Engelhardt J.F. Pancreatic pathophysiology in cystic fibrosis. J Pathol. 2016;238:311-320. doi: 10.1002/path.4634
  11. Chaun H. Colonic disorders in adult cystic fibrosis. Can J Gastroenterol. 2001;15:586-590. PMID: 11573101.
  12. Бабин В.Н., Минушкин О.Н., Дубинин А.В. и др. Молекулярные аспекты симбиоза в системе хозяин - микрофлора. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 1998;(6):76-82.
  13. Ардатская М.Д., Минушкин О.Н., Прихно Н.И., Дубинин А.В. Летучие жирные кислоты и их диагностическое и прогностическое значение в гастроэнтерологической клинике. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2000;Х(5):63-70.
  14. Borg G.A.V. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-381. PMID: 7154893.
  15. American Thoracic Society. Dyspnea: mechanisms, assessment, and management: A Consensus Statement. Am J Respir Crit Care Med. 1999;159:321-340. doi: 10.1164/ajrccm.159.1.ats898
  16. Иконников Н.С., Ардатская М.Д., Бабин В.Н., Минушкин О.Н. и др. Патент на изобретение РФ № 2145511 «Способ разделения смеси жирных кислот фракции С2-С7 методом газожидкостной хроматографии» от 09.04.1999.
  17. Sekirov I, Rusel Sh, Caetano L, et al. Gut microbiota in health and disease. Physiol Rev. 2010;90:859-904. doi: 10.1152/physrev.00045.2009.
  18. De Boeck K, Weren M, Proesmans M, Kerem K. Pancreatitis Among Patients With Cystic Fibrosis: Corellation With Pancreatic Status and Genotype. Pediatrics. 2005;115:e463. doi: 10.1542/peds.2004-1764
  19. Somaraju U.R, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochrane Database Syst Rev. 2016;11:Art. No.: CD008227. doi: 10.1002/14651858.CD008227.pub3
  20. Hunt B, Geddes D.M. Newly diagnosed cystic fibrosis in middle and later life. Thorax. 1985;40:23-26. doi: 10.1136/thx.40.1.23

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies